ShockWave Medical, Inc. (SWAV)

Market Cap	12.57B
Revenue (ttm)	787.97M
Net Income (ttm)	163.50M
Shares Out	37.54M
EPS (ttm)	4.27
PE Ratio	78.40
Forward PE	62.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,947,054
Open	334.85
Previous Close	334.75
Day's Range	334.75 - 334.85
52-Week Range	157.00 - 334.90
Beta	0.88
Analysts	Hold
Price Target	304.00 (-9.19%)
Earnings Date	May 6, 2024

About SWAV

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Mar 7, 2019
• Employees: 1,468
• Stock Exchange: NASDAQ
• Ticker Symbol: SWAV
• Website: https://www.shockwavemedical.com

Financial Performance

In 2023, SWAV's revenue was $730.23 million, an increase of 49.11% compared to the previous year's $489.73 million. Earnings were $147.28 million, a decrease of -31.81%.

Analyst Forecast

According to 10 analysts, the average rating for SWAV stock is "Hold." The 12-month stock price forecast is $304.0, which is a decrease of -9.19% from the latest price.

Price Target

$304.0

(-9.19% downside)

Analyst Consensus: Hold